Table 1 Baseline characteristics of ESB, Non-bleeding, and PIB Patients.
Variable | ESB Group (n = 24) | Non-bleeding Group (n = 24) | P Value* | PIB Group (n = 58) | P Value† |
|---|---|---|---|---|---|
Age, years | 43 (36–47.25) | 45.5 (34.75–49.5) | NS (0.570) | 46 (39–51) | NS (0.155) |
Gender, M/F | 19/5 | 17/7 | NS (0.505) | 48/10 | NS (0.702) |
BMI, kg/m2 | 24.8 (22.2–28.5) | 25.5 (21.17–27.75) | NS (0.836) | 25.25 (23.08–27.59) | NS (0.967) |
Onset to admission, days | 18.5 (5.75–26.5) | 10 (6–41.25) | NS (0.844) | 23 (9.5–40) | NS (0.089) |
Etiology, no. (%) | NS (0.499) | NS (0.99) | |||
Biliary | 13 (54.2) | 16 (66.7) | 32 (55.2) | ||
HTG | 9 (37.5) | 8 (33.3) | 20 (34.5) | ||
Alcoholic | 1 (4.2) | 0 (0) | 3 (5.2) | ||
Other | 1 (4.2) | 0 (0) | 3 (5.2) | ||
Co-morbidities, no. (%) | |||||
Smoking | 10 (41.7) | 8 (33.3) | NS (0.551) | 29 (50.0) | NS (0.492) |
Alcohol use | 12 (50) | 9 (37.5) | NS (0.383) | 24 (41.4) | NS (0.474) |
Hypertension | 7 (29.2) | 11 (45.8) | NS (0.233) | 19 (32.8) | NS (0.750) |
Diabetes mellitus | 5 (20.8) | 7 (29.2) | NS (0.505) | 9 (15.5) | NS (0.560) |
Coronary heart disease | 0 (0) | 2 (8.3) | NS (0.149) | 4 (6.9) | NS (0.187) |
Fatty liver | 3 (12.5) | 5 (20.8) | NS (0.439) | 12 (20.7) | NS (0.383) |
Chronic respiratory disease | 2 (8.3) | 3 (12.5) | NS (0.637) | 8 (13.8) | NS (0.492) |
Chronic renal disease | 0 (0) | 1 (4.2) | NS (0.312) | 1 (1.7) | NS (0.517) |
